Waldenstrom's Macroglobulinemia Program Dana-Farber Cancer Institute
  Publications
  Media
 
 
  Email this page to a friend >

 

   
  Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
6/8/2009
By SP Treon, L Ioakimidis, J Soumerai, C Patterson, P Sheehy, M Nelson, MA Willen, J Matous, J Mattern II, J Diener, G Keogh, TJ Myers, A Boral, A Birner, DL Esseltine, IM Ghobrial
Publisher: Journal of Clinical Oncology

Please refer to attachment.
View Attachment


<< Back